{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:04:14Z","timestamp":1753891454707,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aimed to investigate the characteristics of individuals with amyloid levels below the threshold. To achieve this, we differentiated between two groups: those with global amyloid negativity but focal deposition [G(\u2013)F(+)] and those without focal deposition [G(\u2013)F(\u2013)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A total of 2,677 participants were diagnosed with cognitive unimpairment (CU) or mild cognitive impairment (MCI). MRI-based regional centiloid (CL) values were used to establish threshold values for each brain region. After applying a cutoff of 20 rdcCL to identify amyloid positivity, participants who were globally amyloid-negative were grouped into three categories: those who showed focal amyloid uptake [G(\u2013)F(+)], individuals without focal amyloid deposition but with relatively high CL(HC) levels comparable to those in the focal uptake group [G(\u2013)F(\u2013) HC)], and those with relatively low CL(LC) levels [G(\u2013)F(\u2013) LC]. We compared the neuropsychological test results and brain structural changes between these groups using ANCOVA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The G(\u2013)F(+) group demonstrated a lower cortical thickness (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) than the G(\u2013)F(\u2013) HC group. In neuropsychological tests, the G(\u2013)F(+) group exhibited lower the Seoul Verbal Learning Test delayed recall (SVLT-DR) and Mini Mental State Examination (MMSE), and showed progressed clinical status in the clinical dementia rating\u2013sum of boxes (CDR-SOB) compared to the G(\u2013)F(\u2013) HC group (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The subsequent sensitivity analyses confirmed the persistence of these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Individuals with focal amyloid deposition [G(\u2013)F(+)] exhibited higher rates of cognitive impairment compared to patients with similar levels of amyloid, underscoring the importance of monitoring the progression of focal uptake, even when it remains below the amyloid threshold.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2024.1452081","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T09:26:25Z","timestamp":1730280385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between focal amyloid deposition and cognitive impairment in individuals below the amyloid threshold"],"prefix":"10.3389","volume":"16","author":[{"given":"Hongki","family":"Ham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daeun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihwan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","article-title":"Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients","volume":"25","author":"Ahn","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers. Dement"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","article-title":"Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease","volume":"12","author":"Amadoru","year":"2020","journal-title":"Alzheimers. Res. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13550-018-0456-7","article-title":"Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods","volume":"8","author":"Battle","year":"2018","journal-title":"EJNMMI Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00259-019-04596-x","article-title":"A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB","volume":"47","author":"Cho","year":"","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3233\/JAD-200079","article-title":"Head-to-head comparison of 18F-Florbetaben and 18F-flutemetamol in the cortical and striatal regions","volume":"76","author":"Cho","year":"","journal-title":"J. Alzheimers. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1037\/1040-3590.3.2.168","article-title":"A cognitive battery for dementia: development and measurement characteristics","volume":"3","author":"Christensen","year":"1991","journal-title":"Psychol. Assess."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00259-020-05174-2","article-title":"Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent","volume":"48","author":"Collij","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space","volume":"18","author":"Collins","year":"1994","journal-title":"J. Comput. Assist. Tomogr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2013concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00259-019-04314-7","article-title":"Clinical significance of amyloid \u03b2 positivity in patients with probable cerebral amyloid angiopathy markers","volume":"46","author":"Jang","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.12779\/dnd.2019.18.3.77","article-title":"The cortical neuroanatomy related to specific neuropsychological deficits in Alzheimer's continuum","volume":"18","author":"Kang","year":"2019","journal-title":"Dement. Neurocogn. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.23838\/pfm.2021.00023","article-title":"Finding the optimal cutoff value for amyloid \u03b2 positivity using the iterative outlier method and concordance rate","volume":"5","author":"Kim","year":"2021","journal-title":"Prec. Fut. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1124445","DOI":"10.3389\/fnagi.2023.1124445","article-title":"Clinical outcomes of increased focal amyloid uptake in individuals with subthreshold global amyloid levels","volume":"15","author":"Kim","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.12779\/dnd.2024.23.3.117","article-title":"A comparison of item characteristics and test information between the K-MMSE~2:SV and K-MMSE","volume":"23","author":"Kim","year":"2024","journal-title":"Dement. Neurocogn. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13195-021-00787-7","article-title":"Cognitive trajectories of patients with focal \u00df-amyloid deposition","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimers. Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13195-019-0577-x","article-title":"Clinical significance of focal \u00df-amyloid deposition measured by 18F-flutemetamol PET","volume":"12","author":"Kim","year":"2020","journal-title":"Alzheimers. Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13195-022-01099-0","article-title":"Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET","volume":"14","author":"Kim","year":"2022","journal-title":"Alzheimers. Res. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers. Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.mri.2013.04.008","article-title":"Fully-automated approach to hippocampus segmentation using a graph-cuts algorithm combined with atlas-based segmentation and morphological opening","volume":"31","author":"Kwak","year":"2013","journal-title":"Magn. Reson. Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","article-title":"Subthreshold amyloid predicts tau deposition in aging","volume":"38","author":"Leal","year":"2018","journal-title":"J. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Mckhann","year":"2011","journal-title":"Alzheimers. Dement."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","article-title":"Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale","volume":"14","author":"Navitsky","year":"2018","journal-title":"Alzheimers. Dement."},{"key":"B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","article-title":"18F-Florbetaben PET beta-amyloid binding expressed in Centiloids","volume":"44","author":"Rowe","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2967\/jnumed.115.171595","article-title":"Standardized expression of 18F-NAV4694 and 11C-PiB \u03b2-Amyloid PET results with the Centiloid Scale","volume":"57","author":"Rowe","year":"2016","journal-title":"J. Nucl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans. Med. Imaging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction","volume":"17","author":"Smith","year":"2002","journal-title":"Hum. Brain Mapp."},{"key":"B32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"B33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","article-title":"F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain","volume":"32","author":"Zhang","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1109\/TMI.2002.806283","article-title":"Automatic \u201cpipeline\u201d analysis of 3-D MRI data for clinical trials: application to multiple sclerosis","volume":"21","author":"Zijdenbos","year":"2002","journal-title":"IEEE Trans. Med. Imaging"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1452081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T09:26:27Z","timestamp":1730280387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1452081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":34,"alternative-id":["10.3389\/fnagi.2024.1452081"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1452081","relation":{},"ISSN":["1663-4365"],"issn-type":[{"type":"electronic","value":"1663-4365"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"article-number":"1452081"}}